Thermo Fisher Scientific Inc. (TMO)
Automate Your Wheel Strategy on TMO
With Tiblio's Option Bot, you can configure your own wheel strategy including TMO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol TMO
- Rev/Share 115.7037
- Book/Share 134.9841
- PB 4.2698
- Debt/Equity 0.6993
- CurrentRatio 1.4975
- ROIC 0.08
- MktCap 218437430954.0
- FreeCF/Share 16.1667
- PFCF 35.745
- PE 33.1599
- Debt/Assets 0.3463
- DivYield 0.0029
- ROE 0.1311
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | TMO | Barclays | Equal Weight | Overweight | -- | $550 | Sept. 11, 2025 |
| Initiation | TMO | William Blair | -- | Outperform | -- | -- | Aug. 19, 2025 |
| Downgrade | TMO | HSBC Securities | Buy | Hold | -- | $510 | July 24, 2025 |
| Upgrade | TMO | Scotiabank | Sector Perform | Sector Outperform | -- | $590 | July 11, 2025 |
| Downgrade | TMO | UBS | Buy | Neutral | -- | $460 | July 9, 2025 |
| Upgrade | TMO | Bernstein | Market Perform | Outperform | -- | $630 | Jan. 10, 2025 |
| Initiation | TMO | Scotiabank | -- | Sector Perform | -- | -- | Dec. 23, 2024 |
| Initiation | TMO | Redburn Atlantic | -- | Buy | -- | -- | Oct. 14, 2024 |
| Initiation | TMO | Stephens | -- | Overweight | -- | $680 | Oct. 1, 2024 |
| Initiation | TMO | Wells Fargo | -- | Overweight | -- | $670 | Aug. 28, 2024 |
News
Sethi: Thermo Fisher is a world-class compounder you want in your portfolio
Published: October 29, 2025 by: CNBC Television
Sentiment: Positive
Sarat Sethi, Managing Partner at DCLA, highlights opportunities in undervalued sectors like healthcare and diagnostics, says trade clarity could boost growth, and calls Thermo Fisher a standout pick.
Read More
Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 Billion
Published: October 29, 2025 by: WSJ
Sentiment: Positive
Thermo Fisher Scientific agreed to acquire endpoint data solutions provider Clario Holdings from a shareholder group for $8.88 billion in cash.
Read More
Thermo Fisher to buy clinical services provider Clario
Published: October 29, 2025 by: Reuters
Sentiment: Positive
Thermo Fisher said on Wednesday it would buy privately held data management company Clario for about $8.9 billion in cash and future payments, strengthening the life science firm's presence in digital health and clinical trial research.
Read More
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights
Published: October 29, 2025 by: Business Wire
Sentiment: Neutral
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a definitive agreement to acquire Clario Holdings, Inc., a leading provider of endpoint data solutions for clinical trials, from a shareholder group led by Astorg and Nordic Capital, Novo Holding and Cinven, for $8.875 billion in cash at close plus potential additional earnout and other payments in the future, largely dependent on performance. Clario integrates clinic.
Read More
14-year-old Combines Origami and Physics to Engineer Foldable Structures for Disaster Relief Shelters; Wins $25,000 Top Award at Thermo Fisher Scientific Junior Innovators Challenge
Published: October 28, 2025 by: GlobeNewsWire
Sentiment: Neutral
Miles Wu, 14, from New York City, won the $25,000 Thermo Fisher Scientific ASCEND Award, the top award in the Thermo Fisher Junior Innovators Challenge.
Read More
Pre-Market Futures Flat at This Hour
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Neutral
Pre-Market Futures Flat at This Hour.
Read More
Q3 Earnings Bonanza Pulls a Flat Pre-Market: T, TMO, TSLA, etc.
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Q3 earnings reports released yesterday afternoon did not quite have the positive sheen we've seen elsewhere this far into earnings season.
Read More
Compared to Estimates, Thermo Fisher (TMO) Q3 Earnings: A Look at Key Metrics
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Thermo Fisher (TMO) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
Thermo Fisher's Q3 Earnings & Revenues Top Estimates, Stock Climbs
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Positive
TMO delivers robust Q3 results, fueled by margin growth, new launches and AI-focused strategic initiatives.
Read More
Thermo Fisher Scientific Launches Innovative Carbon Calculator to Drive Greener Clinical Trials
Published: October 21, 2025 by: Business Wire
Sentiment: Neutral
WILMINGTON, N.C.--(BUSINESS WIRE)--Thermo Fisher Scientific Launches Innovative Carbon Calculator to Drive Greener Clinical Trials.
Read More
Countdown to Thermo Fisher (TMO) Q3 Earnings: Wall Street Forecasts for Key Metrics
Published: October 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Thermo Fisher (TMO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.
Read More
TMO to Report Q3 Earnings: Life Science Solutions Segment in Focus
Published: October 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Thermo Fisher's Q3 results on Oct. 22 are set to spotlight gains from new launches and acquisitions across key growth segments.
Read More
Thermo Fisher Scientific (TMO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Neutral
Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Thermo Fisher's New R&D Alliance With AstraZeneca May Lift Its Stock
Published: October 07, 2025 by: Zacks Investment Research
Sentiment: Positive
TMO joins AstraZeneca's BioVentureHub to boost R&D, innovation and life science access.
Read More
Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub
Published: October 01, 2025 by: Business Wire
Sentiment: Neutral
WILMINGTON, N.C.--(BUSINESS WIRE)--Thermo Fisher Scientific announces R&D partnership with AstraZeneca BioVentureHub.
Read More
Thermo Fisher Scientific Showcases the Thermo Fisher Connect Platform at Lab of the Future Europe
Published: September 30, 2025 by: Business Wire
Sentiment: Neutral
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, is sponsoring Lab of the Future Europe this week in Amsterdam, The Netherlands, and will demonstrate how the company's Thermo Fisher™ Connect Platform can integrate and future-proof laboratories. From Digital Ambition to Automated Intelligence In pharma and life sciences, digital transformation is no longer a question of if — but how fast. Many labs remain stuck in a cycle of technical debt and shado.
Read More
BenchSci Announces Strategic Partnership with Thermo Fisher Scientific to Create AI-powered Tools to Accelerate R&D Productivity
Published: September 30, 2025 by: Business Wire
Sentiment: Neutral
TORONTO--(BUSINESS WIRE)--BenchSci today announced a strategic partnership with Thermo Fisher Scientific Inc. to create AI-powered tools to accelerate R&D productivity.
Read More
HOLX vs. TMO: Which Diagnostic Giant Is the Stronger Buy Today?
Published: September 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Diagnostic leaders Hologic and Thermo Fisher post raised outlooks, acquisitions and strong product momentum.
Read More
Thirty Inspiring Middle School Scientists and Engineers Shine as Finalists in the Thermo Fisher Scientific Junior Innovators Challenge
Published: September 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
WASHINGTON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Society for Science today announced the 30 finalists in the Thermo Fisher Scientific Junior Innovators Challenge (Thermo Fisher JIC), the nation's premier middle school science, technology, engineering and mathematics (STEM) competition.
Read More
The New Olink Target 48 Neurodegeneration Panel May Boost TMO Stock
Published: September 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Thermo Fisher unveils the Olink Target 48 Neurodegeneration panel to accelerate biomarker research in neurodegenerative diseases.
Read More
Should You Continue to Hold Thermo Fisher Stock in Your Portfolio?
Published: August 28, 2025 by: Zacks Investment Research
Sentiment: Negative
TMO's growth, driven by new partnerships and strong end markets, faces challenges from macro pressures and fierce competition.
Read More
Thermo Fisher (TMO) Up 1.8% Since Last Earnings Report: Can It Continue?
Published: August 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock?
Read More
Thermo Fisher Scientific Opens Manufacturing Center of Excellence Site in North Carolina
Published: August 21, 2025 by: Business Wire
Sentiment: Neutral
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the grand opening of its innovative manufacturing center of excellence facility in Mebane, N.C. The new 375,000-square-foot carbon neutral site will be capable of producing at least 40 million laboratory pipette tips per week, helping to ensure that life-saving medicines and therapies continue to be developed and produced in the U.S. for decades to come. “As a global leader in li.
Read More
TMO Receives FDA Approval for Oncomine Dx Target Test
Published: August 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Thermo Fisher secures FDA approval for its Oncomine Dx Target Test to identify NSCLC patients eligible for HERNEXEOS treatment.
Read More
Final Trades: Toast, Transdigm, Thermo Fisher and Amazon
Published: August 13, 2025 by: CNBC Television
Sentiment: Neutral
The Investment Committee give you their top stocks to watch for the second half.
Read More
Thermo Fisher Q2: Pharma And Biotech Gains Offset By Weak Academic And Gov't Markets
Published: August 06, 2025 by: Seeking Alpha
Sentiment: Positive
I reiterate my Buy rating on Thermo Fisher Scientific Inc., with a fair value estimate of $568 per share, reflecting its undervalued stock price. Q2 FY25 results showed early signs of market recovery, with 2% organic revenue growth and raised full-year revenue and EPS guidance. Pharma and biotech segments are recovering, but academic and government markets face headwinds from U.S. funding uncertainties and policy risks.
Read More
Trade tracker: Bill Baruch buys Thermo Fisher
Published: August 01, 2025 by: CNBC Television
Sentiment: Positive
Bill Baruch, founder and president at Blue Line Capital, joins CNBC's “Halftime Report” to explain why he's buying Thermo Fisher here.
Read More
Thermo Fisher Scientific Showcases Diagnostics Solutions Designed to Meet Evolving Global Healthcare Demands at ADLM 2025
Published: July 28, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, showcases its innovations in improving clinical and diagnostic laboratory efficiency and workflow optimization during the Association for Diagnostics & Laboratory Medicine Conference (ADLM), July 27-31, 2025, in Chicago, Ill. The company debuts two new solutions, LabLink360™* and Thermo Scientific™ MAS™ Max quality controls, designed to support quality control assurance and streamline workflows in clini.
Read More
Thermo Fisher Scientific Stock Jumps on Strong Results, Higher Outlook
Published: July 23, 2025 by: Investopedia
Sentiment: Positive
Thermo Fisher Scientific (TMO) shares took off after the maker of lab equipment and other life sciences products posted better-than-expected results and boosted its guidance, citing operational improvements and lower expected impacts from new tariffs.
Read More
Thermo Fisher shares surge after Q2 beat, boosted by product launches
Published: July 23, 2025 by: Proactive Investors
Sentiment: Positive
Shares of Thermo Fisher Scientific Inc (NYSE:TMO, ETR:TN8) jumped nearly 12% on Wednesday morning after the company reported second-quarter results that topped Wall Street estimates, fueled by strong demand across its life sciences and diagnostics segments. The company posted revenue of $10.86 billion, surpassing analysts' expectations of $10.69 billion and marking a 3% year-over-year increase.
Read More
About Thermo Fisher Scientific Inc. (TMO)
- IPO Date 1980-03-17
- Website https://www.thermofisher.com
- Industry Medical - Diagnostics & Research
- CEO Marc N. Casper
- Employees 125000